SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-073405
Filing Date
2023-06-21
Accepted
2023-06-21 17:15:20
Documents
12
Period of Report
2023-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319369d1_8k.htm   iXBRL 8-K 44850
  Complete submission text file 0001104659-23-073405.txt   220013

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lptx-20230616.xsd EX-101.SCH 3221
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20230616_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20230616_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2319369d1_8k_htm.xml XML 3596
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 231030808
SIC: 2834 Pharmaceutical Preparations